Class information for:
Level 1: SERUM MEDIATORS//LY2216684//NEPHROLOGY CLINICAL PRACTICE GUIDELINES

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
21741 350 35.6 63%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
3517 997 APA HAMSTER//APA HAMSTERS//AMINO ACID LOAD

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SERUM MEDIATORS Author keyword 4 75% 1% 3
2 LY2216684 Author keyword 3 100% 1% 3
3 NEPHROLOGY CLINICAL PRACTICE GUIDELINES Author keyword 3 100% 1% 3
4 EDIVOXETINE Author keyword 3 60% 1% 3
5 DOSAGE ADJUSTMENT Author keyword 2 20% 3% 10
6 KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE Author keyword 2 50% 1% 3
7 UREMIC SERUM Author keyword 1 38% 1% 3
8 CLIN PHARM PROGRAMME Address 1 50% 1% 2
9 NEPHROLOGY PRECEPTOR Author keyword 1 100% 1% 2
10 NATIONAL KIDNEY FOUNDATION Author keyword 1 23% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SERUM MEDIATORS 4 75% 1% 3 Search SERUM+MEDIATORS Search SERUM+MEDIATORS
2 LY2216684 3 100% 1% 3 Search LY2216684 Search LY2216684
3 NEPHROLOGY CLINICAL PRACTICE GUIDELINES 3 100% 1% 3 Search NEPHROLOGY+CLINICAL+PRACTICE+GUIDELINES Search NEPHROLOGY+CLINICAL+PRACTICE+GUIDELINES
4 EDIVOXETINE 3 60% 1% 3 Search EDIVOXETINE Search EDIVOXETINE
5 DOSAGE ADJUSTMENT 2 20% 3% 10 Search DOSAGE+ADJUSTMENT Search DOSAGE+ADJUSTMENT
6 KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE 2 50% 1% 3 Search KIDNEY+DISEASE+OUTCOMES+QUALITY+INITIATIVE Search KIDNEY+DISEASE+OUTCOMES+QUALITY+INITIATIVE
7 UREMIC SERUM 1 38% 1% 3 Search UREMIC+SERUM Search UREMIC+SERUM
8 NEPHROLOGY PRECEPTOR 1 100% 1% 2 Search NEPHROLOGY+PRECEPTOR Search NEPHROLOGY+PRECEPTOR
9 NATIONAL KIDNEY FOUNDATION 1 23% 1% 3 Search NATIONAL+KIDNEY+FOUNDATION Search NATIONAL+KIDNEY+FOUNDATION
10 MEDICATION RELATED PROBLEMS 1 14% 1% 5 Search MEDICATION+RELATED+PROBLEMS Search MEDICATION+RELATED+PROBLEMS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 L PROPRANOLOL 33 100% 4% 13
2 AMBULATORY HEMODIALYSIS PATIENTS 7 53% 3% 10
3 HEPATIC CYTOCHROME P450 3 12% 6% 21
4 DRUG RELATED PROBLEMS 3 15% 5% 17
5 DOSAGE ADJUSTMENTS 2 67% 1% 2
6 IMPLEMENTED ANEMIA MANAGEMENT 2 67% 1% 2
7 JOINT OPINION 2 67% 1% 2
8 MEDICATION RELATED PROBLEMS 2 36% 1% 4
9 INTESTINAL CYTOCHROME P450 2 43% 1% 3
10 DOSING GUIDELINES 1 30% 1% 3

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport 2014 16 49 59%
The effect of chronic renal failure on drug metabolism and transport 2008 55 63 57%
Drug-related problem in children with chronic kidney disease 2013 6 22 45%
Consequences of Renal Failure on Non-Renal Clearance of Drugs 2014 4 88 57%
Emerging Areas of Research in the Assessment of Pharmacokinetics in Patients With Chronic Kidney Disease 2015 1 41 12%
Altered nonrenal drug clearance in ESRD 2008 28 43 51%
Polypharmacy and medication-related complications in the chronic kidney disease patient 2011 7 10 60%
Pharmacokinetics and dosage adjustment in patients with renal dysfunction 2009 63 100 26%
The effect of chronic renal failure on hepatic drug metabolism and drug disposition 2003 58 40 40%
Effects of renal failure on drug transport and metabolism 2006 119 94 18%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CLIN PHARM PROGRAMME 1 50% 0.6% 2
2 CENT SUPPORT SERV 1 50% 0.3% 1
3 CLIN PHARM IQ HEALTHCARE 1 50% 0.3% 1
4 E HLTH STRATEG IT 1 50% 0.3% 1
5 EPHE PHYSIOL 1 50% 0.3% 1
6 MED E FAMILY PRACTICE IDENCY PROGRAM 1 50% 0.3% 1
7 SANOFI AVENTIS ENDOWMENT CHAIR AMBULATORY PHARMA 1 50% 0.3% 1
8 SANOFI AVENTIS ENDOWMENT CHAIR AMBULATORY PHARMAC 1 25% 0.6% 2
9 ALBANY NEPHROL PHARM GRP 1 22% 0.6% 2
10 PHYSIOL PHARM CLIN 0 33% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000129531 INDOXYL SULFATE//P CRESYL SULFATE//AST 120
2 0.0000128302 APA HAMSTER//APA HAMSTERS//ATHEROMATOUS LESION
3 0.0000122696 CLONIC CONVULSION//INDUCED SEIZURES//BEMEGRIDE
4 0.0000094089 MEDICATION RECONCILIATION//MEDICATION DISCREPANCIES//MEDICINES RECONCILIATION
5 0.0000092883 ASAN FDN//DA 125//MED DIAGNOST PATHOL
6 0.0000090767 AMINO ACID LOAD//GALLBLADDER OPACIFICATION//P AMINOHIPPURATE TRANSPORT
7 0.0000083863 LATE REFERRAL//NEPHROLOGY REFERRAL//CHRONIC KIDNEY DISEASE CKD
8 0.0000076493 CYSTATIN C//GLOMERULAR FILTRATION RATE//COCKCROFT GAULT
9 0.0000068949 BEERS CRITERIA//POLYPHARMACY//POTENTIALLY INAPPROPRIATE MEDICATIONS
10 0.0000063703 PHARMACEUTICAL CARE//COMMUNITY PHARMACY//MEDICATION THERAPY MANAGEMENT